Efficacy of Infliximab comparing with Cyclophosphamide in refractory uveitis in Behcet’s diseases
Phase 3
- Conditions
- Refractory uveitis in patients with Behcet.Behcet's disease
- Registration Number
- IRCT20180110038297N1
- Lead Sponsor
- Zanjan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Behcet’s disease
Refractory uveitis
Retinal vesiculitis
Exclusion Criteria
Patient dissatisfaction
Contraindications for administration of Infliximab or cyclophosphamide
Non response to medication
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method